glp-1 suicide FDA says no 'clear relationship' between drugs and risk FDA Moves To Remove Suicide

Some data suggest neuroprotective properties, and there are ongoing randomised trials among patients with neurological and psychiatric disorders (NCT04466345)

Its method of action involves binding to ghrelin receptors, specifically the Growth Hormone Secretagogue Receptor (GHS-R1a), located in the hypothalamus and pituitary gland

It occupies a niche almost nothing else does, it feeds the bacteria that produce butyrate, and in a human trial it raised GLP-1, a hormone central to appetite and blood sugar

[2] Pickart, L., Vasquez-Soltero, J

Mold Toxicity and Lyme Disease Mold illness causes many of the same symptoms as Lyme disease